Log in
Enquire now
‌

US Patent 7655254 Implantable device for continuous delivery of interferon

Patent 7655254 was granted and assigned to Intarcia Therapeutics on February, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Intarcia Therapeutics
Intarcia Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
76552540
Patent Inventor Names
Catherine M. Rohloff0
Paula Dennis0
Pauline C. Zamora0
Stan Lam0
James E. Matsuura0
Kui Liu0
Latha Narayanan0
Michael A. Desjardin0
Date of Patent
February 2, 2010
0
Patent Application Number
113476010
Date Filed
February 3, 2006
0
Patent Citations Received
‌
US Patent 11840559 Glucagon-receptor selective polypeptides and methods of use thereof
0
0
‌
US Patent 11654183 Methods comprising continuous administration of exenatide and co-administration of a drug
0
Patent Primary Examiner
‌
Lorraine Spector
0
Patent abstract

An implantable device includes a reservoir containing a suspension of an interferon in an amount sufficient to provide continuous delivery of the interferon at a therapeutically effective rate of 1 ng/day to 600 μg/day to maintain and achieve therapeutic blood or plasma levels of the interferon throughout a substantial period of the administration period.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7655254 Implantable device for continuous delivery of interferon

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us